- Home
- MCB vs IMTX Comparison
MCB vs IMTX Comparison
Compare MCB & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCB
- IMTX
- Stock Information
- Founded
- MCB 1999
- IMTX N/A
- Country
- MCB United States
- IMTX Germany
- Employees
- MCB N/A
- IMTX N/A
- Industry
- MCB Major Banks
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MCB Finance
- IMTX Health Care
- Exchange
- MCB Nasdaq
- IMTX Nasdaq
- Market Cap
- MCB 693.0M
- IMTX 559.1M
- IPO Year
- MCB 2017
- IMTX N/A
- Fundamental
- Price
- MCB $59.19
- IMTX $4.60
- Analyst Decision
- MCB Buy
- IMTX Strong Buy
- Analyst Count
- MCB 4
- IMTX 4
- Target Price
- MCB $71.00
- IMTX $16.67
- AVG Volume (30 Days)
- MCB 74.2K
- IMTX 1.2M
- Earning Date
- MCB 04-17-2025
- IMTX 03-20-2025
- Dividend Yield
- MCB N/A
- IMTX N/A
- EPS Growth
- MCB N/A
- IMTX N/A
- EPS
- MCB 5.93
- IMTX N/A
- Revenue
- MCB $270,656,000.00
- IMTX $128,824,447.00
- Revenue This Year
- MCB N/A
- IMTX $116.22
- Revenue Next Year
- MCB $13.98
- IMTX N/A
- P/E Ratio
- MCB $10.02
- IMTX N/A
- Revenue Growth
- MCB 13.50
- IMTX 52.53
- 52 Week Low
- MCB $32.46
- IMTX $4.48
- 52 Week High
- MCB $69.56
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- MCB 38.53
- IMTX 27.20
- Support Level
- MCB $61.03
- IMTX $4.85
- Resistance Level
- MCB $62.49
- IMTX $5.25
- Average True Range (ATR)
- MCB 2.26
- IMTX 0.28
- MACD
- MCB -0.50
- IMTX -0.01
- Stochastic Oscillator
- MCB 2.61
- IMTX 8.96
About MCB Metropolitan Bank Holding Corp.
Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.